Table 3 Distribution of antibiotics susceptibility pattern for isolated gram negative microbials from septic patients in Adult ICU, ACSH, 2017
Antibiotic | Sensitivity pattern | Klebsiella sensitivity % (isolates no) | Pseudomonas sensitivity % (isolates no) | Escherichia coli sensitivity % (isolates no) | Acinetobacter sensitivity % (isolates no) | Citrobacter sensitivity % (isolates no) |
|---|---|---|---|---|---|---|
Ampicillin | R | 100 (17/17) | 100 (5/5) | 89 (8/9) | 100 (5/5) | 100 (3/3) |
S | – | – | 11 (1/9) | – | – | |
Penicillin | R | – | – | 100 (1/1) | 100 (1/1) | – |
Tetracycline | R | 90 (9/10) | 100 (2/2) | 83.3 (5/6) | 100 (4/4) | 100 (3/3) |
S | 10 | – | 16.7 | – | – | |
Doxycycline | R | 66.7 (2/3) | 100 (2/2) | 100 (3/3) | 66.7 (2/3) | 100 (1/1) |
S | 33.3 | – | – | 33.3 | – | |
Chloramphenicol | R | 71.4 (5/7) | 100 (2/2) | 66.7 (2/3) | 100 (3/3) | 100 (3/3) |
S | 28.6 | – | 33.3 | – | – | |
Ciprofloxacin | R | 62.5 (10/16) | 30()3/10) | 77.8 (7/9) | 83.3 (5/6) | 100 (3/3) |
S | 25 | 50 | 11.1 | – | – | |
I | 12.5 | 20 | 11.1 | 16.7 | – | |
Gentamycin | R | 58.3 (7/12) | 57.1 (4/7) | 60 (3/5) | 100 (3/3) | 100 (3/3) |
S | 16.7 | 14.3 | 20 | – | – | |
I | 25 | 28.6 | 20 | – | – | |
Cotrimoxazole | R | 92.3 (12/13) | 100 (2/2) | 75 (3/4) | 100 (3/3) | 100 (3/3) |
Augmentin | R | 100 (13/13) | 100 (2/2) | 100 (4/4) | 100 (4/4) | 100 (3/3) |
Amikacin | R | 60 (3/5) | 25 (2/8) | 100 (1/1) | 100 (3/3) | 100 (2/2) |
S | 20 | 37.5 (3/8) | – | – | – | |
I | 20 | 37.5 (3/8) | – | – | – | |
Cephalothin | R | 100 (12/12) | 100 (1/1) | 100 (4/4) | 100 (2/2) | 100 (1/1) |
Piperacillin | R | 100 (1/1) | 25 (1/3) | 100 (1/1) | 100 (2/2) | 100 (1/1) |
Ceftriaxone | R | 100 (8/8) | 100 (1/1) | 100 (4/4) | 100 (1/1) | |
S | – | 100 (1/1) | – | |||
Ceftazidime | R | 100 (9/9) | 42.9 (3/7) | 100 (1/1) | 100 (5/5) | 100 (1/1) |
S | – | 57.1 | – | – | ||
Meropenem | R | 10 (1/10) | 50 (2/2) | – | 100 (4/4) | 100 (1/1) |
S | 70 (7/10) | 50 | 100 (1/1) | – | ||
I | 20 | – | – | – | – | |
Tobramycin | R | 66.7 (2/3) | 42.8 (3/5) | – | – | – |
S | 33.3 | 28.6 | – | – | – | |
I | – | 28.6 | – | – | – | |
Cefepime | R | 100 (3/3) | – | – | 100 (4/4) | – |
S | – | 100 (3/3) | – | – |